Zhejiang Conba Pharmaceutical Co (SHSE:600572) EPS Growth Rate (Future 3Y To 5Y Estimate) : N/A (As of Jun. 03, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Zhejiang Conba Pharmaceutical Co EPS Growth Rate (Future 3Y To 5Y Estimate)?

EPS Growth Rate (Future 3Y To 5Y Estimate) is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Zhejiang Conba Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) is N/A.

Competitive Comparison of Zhejiang Conba Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate)

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Conba Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate), along with its competitors' market caps and EPS Growth Rate (Future 3Y To 5Y Estimate) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Conba Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Conba Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) distribution charts can be found below:

* The bar in red indicates where Zhejiang Conba Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) falls into.

Zhejiang Conba Pharmaceutical Co (SHSE:600572) EPS Growth Rate (Future 3Y To 5Y Estimate) Explanation

EPS Growth Rate (Future 3Y To 5Y Estimate) s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Zhejiang Conba Pharmaceutical Co EPS Growth Rate (Future 3Y To 5Y Estimate) Related Terms

Thank you for viewing the detailed overview of Zhejiang Conba Pharmaceutical Co's EPS Growth Rate (Future 3Y To 5Y Estimate) provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhejiang Conba Pharmaceutical Co (SHSE:600572) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Conba Pharmaceutical Co Ltd (SHSE:600572) » Definitions » EPS Growth Rate (Future 3Y To 5Y Estimate)

Traded in Other Exchanges

N/A

Address

No. 568 Binkang Road, New and High-Technology Development Zone, Binjiang District, Zhejiang, Hangzhou, CHN, 310052

Website

http://www.conba.com.cn

Zhejiang Conba Pharmaceutical Co Ltd operates as a pharmaceutical company in China. It offers traditional Chinese medicines, botanical extracts, chemical medicines, chemical raw medicines, health foods, common foods, prepared drugs in pieces, and commodities. It provides its products under the Conba, Prostate Plus, Zhenshiming, Tianbaoning, Alocin, Xitao, Yuanbang, Baby, and Omeprazole names.

Executives

Hu Ji Qiang	Director
Yuan Zhen Xian	senior management
Yin Shi Shui	Supervisors
Xu Chun Ling	senior management
Jin Zu Cheng	Directors, senior managers
Ye Jian Feng	Supervisors
Ying Chun Xiao	Director
Chen Ming	Director
Luo Guo Liang	Director
Wu Zhong Shi	Supervisors
Wang Ru Wei	Director
Yang Jun De	senior management
Yang Xian Min	senior management
Chen Yue Zhong	senior management
Li Jian Zhong	Supervisors

Zhejiang Conba Pharmaceutical Co (SHSE:600572) Headlines

No Headlines